德塞佩卢马布治疗对感知喘触发者的影响:一个多中心实践研究
Andrea Portacci1, Giulia Scioscia2, Silvano Dragonieri1
1Institute of Respiratory Disease, Department of Translational Biomedicine and neuroscience, University "Aldo Moro", Bari, Italy.
概括
佩鲁马布显著改善了严重喘患者对触发因素和生活质量的感知. 这种单克隆抗体疗法有助于控制触发器过敏症,这是严重喘的关键因素.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 临床医学 临床医学
背景情况:
- 喘恶化通常是由感染,过敏原,运动和刺激物引起的,从而降低了患者的生活质量.
- 有效的触发管理对于严重喘护理至关重要.
- 作为一种抗胸腺侧膜淋巴质蛋白 (TSLP) 单克隆抗体的Tezepelumab可减少恶化,但其对触发感知的影响尚不清楚.
研究的目的:
- 调查特泽佩卢马布对严重喘患者对喘触发因素和与健康相关的生活质量 (HRQoL) 的感知的影响.
- 为了评估在tzepelumab治疗后触发特异性症状和整体喘控制的变化.
主要方法:
- 一项观察性多中心研究包括30名严重喘患者,每4周服用210毫克特泽佩卢马布.
- 喘触发因素使用喘触发因素清单 (ATI) 进行评估.
- 在基线和3个月使用喘控制测试 (ACT),喘控制问卷 (ACQ) 和喘生活质量问卷 (AQLQ) 测量呼吸系统症状和HRQoL.
主要成果:
- 采佩卢马布治疗导致喘触发物的感知影响显著减少,并改善HRQoL.
- 患者报告了ATI的"空气污染/刺激物"和"感染"领域的具体改善.
- 在研究期间,ATI和AQLQ分数的变化之间发现了显著的相关性.
结论:
- 佩鲁马布积极影响患者对喘触发物的感知,并在严重喘中增强HRQoL.
- 这些发现支持将触发器过敏性视为可治疗的特征,用于用tezepelumab治疗严重喘.
- 需要进一步的研究来探索特泽佩卢马布对触发感知的潜在机制和长期影响.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
156
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
156
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
01:20Asthma: Pathogenesis and Management
231
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
231